IPO Trending
MONOPHARMASME / NSEListed

Mono Pharmacare Limited

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.

₹26 - ₹2813.47x sub
Listed Price29.00
Listing Gain+3.57%
ProspectusOfficial exchange filings and draft red herring documents
Mono Pharmacare Limited IPO Documents | GMP, Allotment & Financials | IPO Trending